TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
-4.45%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$10.5B
AUM Growth
+$4.68B
(+81%)
Cap. Flow
+$5.03B
Cap. Flow
% of AUM
48.1%
Top 10 Holdings %
Top 10 Hldgs %
29.39%
Holding
7,240
New
777
Increased
2,878
Reduced
2,426
Closed
830
Top Buys
| 1 |
Apple
AAPL
|
+$429M |
| 2 |
Microsoft
MSFT
|
+$350M |
| 3 |
Amazon
AMZN
|
+$222M |
| 4 |
Tesla
TSLA
|
+$150M |
| 5 |
NVIDIA
NVDA
|
+$137M |
Top Sells
| 1 |
Technology Select Sector SPDR Fund
XLK
|
+$51.9M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$45.3M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$35.2M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$27.5M |
| 5 |
iShares Russell 1000 ETF
IWB
|
+$11.9M |
Sector Composition
| 1 | Technology | 30.52% |
| 2 | Consumer Discretionary | 11.81% |
| 3 | Healthcare | 9.84% |
| 4 | Communication Services | 9.46% |
| 5 | Financials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4476
PennantPark Floating Rate Capital
PFLT
$970M
| $9K | ﹤0.01% |
640
+245
| +62% | +$3.45K |
|
4477
Plus Therapeutics
PSTV
$41.4M
| $9K | ﹤0.01% |
632
+630
| +31,500% | +$8.97K |
|
4478
PIMCO Corporate & Income Opportunity Fund
PTY
$2.75B
| $9K | ﹤0.01% |
+578
| New | +$9K |
|
4479
PubMatic
PUBM
$395M
| $9K | ﹤0.01% |
337
-270
| -44% | -$7.21K |
|
4480
Qualigen Therapeutics
QLGN
$3.83M
| $9K | ﹤0.01% |
+27
| New | +$9K |
|
|
RC
4481
Ready Capital
RC
$698M
| $9K | ﹤0.01% |
583
-5
| -0.9% | -$77 |
|
4482
REX American Resources
REX
$497M
| $9K | ﹤0.01% |
267
-11,277
| -98% | -$380K |
|
4483
Rallybio
RLYB
$23.8M
| $9K | ﹤0.01% |
1,312
-1,321
| -50% | -$9.06K |
|
4484
RenovoRx
RNXT
$44.7M
| $9K | ﹤0.01% |
3,076
+2,185
| +245% | +$6.39K |
|
4485
Safe Bulkers
SB
$467M
| $9K | ﹤0.01% |
1,739
-880
| -34% | -$4.55K |
|
4486
SI-BONE Inc
SIBN
$635M
| $9K | ﹤0.01% |
405
-16
| -4% | -$356 |
|
4487
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$15.9M
| $9K | ﹤0.01% |
+86
| New | +$9K |
|
4488
Semler Scientific
SMLR
$410M
| $9K | ﹤0.01% |
186
+83
| +81% | +$4.02K |
|
4489
Sanara MedTech
SMTI
$304M
| $9K | ﹤0.01% |
310
+260
| +520% | +$7.55K |
|
4490
Scorpio Tankers
STNG
$3.07B
| $9K | ﹤0.01% |
413
-1,454
| -78% | -$31.7K |
|
4491
Stereotaxis
STXS
$251M
| $9K | ﹤0.01% |
2,315
+1,226
| +113% | +$4.77K |
|
4492
Smith & Wesson
SWBI
$418M
| $9K | ﹤0.01% |
576
-8,011
| -93% | -$125K |
|
4493
Transact Technologies
TACT
$46M
| $9K | ﹤0.01% |
1,403
+798
| +132% | +$5.12K |
|
|
TBI
4494
Trueblue
TBI
$184M
| $9K | ﹤0.01% |
328
-1,757
| -84% | -$48.2K |
|
4495
TriCo Bancshares
TCBK
$1.47B
| $9K | ﹤0.01% |
231
-264
| -53% | -$10.3K |
|
4496
Talphera
TLPH
$19.3M
| $9K | ﹤0.01% |
1,596
+975
| +157% | +$5.5K |
|
4497
Transmedics
TMDX
$4.08B
| $9K | ﹤0.01% |
339
-1,843
| -84% | -$48.9K |
|
4498
ReposiTrak
TRAK
$313M
| $9K | ﹤0.01% |
1,787
+1,136
| +175% | +$5.72K |
|
4499
ProShares Ultra Gold
UGL
$749M
| $9K | ﹤0.01% |
536
| – | – |
|
4500
UroGen Pharma
URGN
$837M
| $9K | ﹤0.01% |
1,089
-1,116
| -51% | -$9.22K |
|